CNS Pharmaceuticals Inc (CNSP)
0.1409
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.135
-0.01
(-4.19%)
After-Hours: 20:00
CNS Pharmaceuticals Free Cash Flow: -10.76M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
June 30, 2024 | -10.76M |
March 31, 2024 | -12.51M |
December 31, 2023 | -14.14M |
September 30, 2023 | -13.91M |
June 30, 2023 | -12.35M |
March 31, 2023 | -12.31M |
December 31, 2022 | -10.56M |
September 30, 2022 | -11.50M |
June 30, 2022 | -11.68M |
March 31, 2022 | -13.31M |
Date | Value |
---|---|
December 31, 2021 | -13.54M |
September 30, 2021 | -11.75M |
June 30, 2021 | -11.03M |
March 31, 2021 | -8.786M |
December 31, 2020 | -7.336M |
September 30, 2020 | -8.376M |
June 30, 2020 | -7.481M |
March 31, 2020 | -5.352M |
December 31, 2019 | -3.554M |
Free Cash Flow Range, Past 5 Years
-14.14M
Minimum
Dec 2023
-3.554M
Maximum
Dec 2019
-10.54M
Average
-11.50M
Median
Sep 2022
Free Cash Flow Benchmarks
NovaBay Pharmaceuticals Inc | -3.396M |
Palatin Technologies Inc | -33.83M |
iBio Inc | -18.55M |
Theriva Biologics Inc | -18.01M |
Oragenics Inc | -7.214M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -1.650M |
Cash from Financing (Quarterly) | 2.327M |
Free Cash Flow Per Share (Quarterly) | -4.382 |
Free Cash Flow Yield | -40.24K% |